Sonara Health completed undisclosed amount Strategic Round funding
Sector:
Healthcare
08/19/2025
Dallas, TX USA
Sonara Health
completed undisclosed amount Strategic Round funding. Investors include
Acumen America, Sorenson Impact Foundation, Boomerang Ventures, First Trust Capital Partners.
"We believe fewer lives would be lost to opioid dependency if treatment barriers were eliminated," said Michael Giles, MD, Founder and CEO of Sonara. "This funding positions us to scale those efforts and partner with forward-thinking providers, payers, and policymakers to reimagine what equitable, tech-enabled methadone care can look like."
About
Sonara Health is transforming methadone treatment through a hybrid care platform that makes it easier for people with opioid use disorder (OUD) to start and stay in treatment. By combining in-person care with virtual tools, Sonara removes common barriers, like daily clinic travel, that often affect treatment retention. At the core of the platform is Sonara's patented, tamper-aware medication adherence system, the Virtual Dosing Window™, which enables patients to securely record doses from home while maintaining clinical oversight. The platform also supports remote intake, telecounseling, in-app messaging, and real-time adherence insights, helping care teams stay connected to patients between visits and make more informed clinical decisions. Clinically validated in a peer-reviewed NIH-funded study, Sonara is now used in over 50 locations across 14 states and is helping opioid treatment programs improve retention, build trust with patients, and expand access to life-saving care.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
